Search clinical trials for: Immunotherapeutic treatment

Total 63678 results

Zhejiang Cancer Hospital

Not yet recruiting

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Non-small Cell Lung Cancer Stage III
National Cancer Institute (NCI)

Recruiting

Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer

Oropharyngeal Squamous Cell Carcinoma (SCC)

United States
OSE Immunotherapeutics

Recruiting

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis (CoTikiS)

Ulcerative Colitis

Belgium, Latvia, Bulgaria, Belarus, Croatia, Georgia, Hungary, Poland, Russian Federation, South Africa, Ukraine
Institut Bergonié
French Sarcoma Group

Recruiting

National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group (BCB-Sarcomes)

Sarcoma

France
University of Colorado, Denver
The Leona M. and Harry B. Helmsley Charitable Trust; Nova Immunotherapeutics...

Recruiting

MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes (MER3101)

Type 1 Diabetes Mellitus

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Ovarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditions

United States, Puerto Rico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Cryoablation for the Treatment of Metastatic Cancer

Metastatic Malignant Neoplasm

United States
MoonLake Immunotherapeutics AG

Completed

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa

Germany, United States, Bulgaria, Canada, Ireland, Netherlands, Poland
MoonLake Immunotherapeutics AG

Completed

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

Arthritis, Psoriatic

United States, Spain, Bulgaria, Poland, Czechia, Estonia, Germany, Hungary
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals

Withdrawn

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Hepatitis B Virus

United States, Thailand, Canada, Brazil
GlaxoSmithKline

Terminated

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer (INDUCT)

Neoplasms, Breast

United States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
GlaxoSmithKline

Terminated

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

Melanoma

United States, Australia, Spain, Taiwan, Bulgaria, Estonia, Germany, Belgium, France, Sweden, Israel, Poland, Italy, Czechia, Switzerland, Korea, Republic of, Ireland, Canada, Argentina, Netherlands, Russian Federation, Ukraine, Aus... and more
GlaxoSmithKline

Completed

A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma (PREDICT)

Melanoma

United States, Spain, Germany, France, Poland, Italy, Ireland, Russian Federation
GlaxoSmithKline

Completed

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer

Melanoma

Germany, Czechia, France, Italy, Russian Federation, Poland
Amgen Research (Munich) GmbH

Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) (BLAST)

B-cell Acute Lymphoblastic Leukemia

Austria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
Panacela Labs LLC

Unknown

A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Prostate Cancer

Russian Federation
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States, United Kingdom, Germany, Spain, France, Italy
Amgen Research (Munich) GmbH

Completed

Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)

B-ALL

Germany
Amgen Research (Munich) GmbH

Completed

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma

Germany
Amgen Research (Munich) GmbH

Completed

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

Germany
Argos Therapeutics

Completed

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Renal Cell Carcinoma

United States, Canada
Duke University
Immunotope

Completed

Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Breast Cancer

United States
Argos Therapeutics

Completed

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

HIV Infections

Canada, United States
Artielle ImmunoTherapeutics

Unknown

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

United States
Case Comprehensive Cancer Center

Not yet recruiting

Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care (PARTNERS)

Cancer

United States
Sun Yat-sen University

Not yet recruiting

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Hepatocellular Carcinoma
Barwon Health
Global Alliance for TB Drug Development

Not yet recruiting

Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT-BU)

Buruli Ulcer
Hebei Medical University Fourth Hospital
Fudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaborators

Recruiting

Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study

Esophageal Neoplasm

China
IRCCS San Raffaele

Not yet recruiting

Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital

Hypovitaminosis D
McMaster University

Not yet recruiting

Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation

Diabetic Neuropathies

Canada
First Affiliated Hospital of Zhejiang University
The First People's Hospital of Huzhou; People's Hospital of Guangxi; The second... and other collaborators

Not yet recruiting

Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock

Sepsis | Septic Shock | Methylene Blue
Nanjing First Hospital, Nanjing Medical University

Not yet recruiting

Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression

Depression | Functional Dyspepsia
Nanjing First Hospital, Nanjing Medical University

Not yet recruiting

Zuojin Wan Combined With Woonosan Fumarate for the Treatment of GRD Combined With Depression

Depression | Gastroesophageal Reflux Disease
Mayo Clinic

Not yet recruiting

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Recurrent... and other conditions

United States
West China Hospital

Recruiting

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

Locally Advanced Thyroid Gland Carcinoma

China
Oslo Metropolitan University

Not yet recruiting

Treatment of Phantom Limb Pain by Intensive Visual Stimulation Therapy

Phantom Limb Pain
Rui Yang

Recruiting

Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency (aSVF-POI)

Premature Ovarian Insufficiency

China
Christian Schmidt, MD
Johannes Gutenberg University Mainz

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma (CARMAN)

Mantle Cell Lymphoma

Germany
Ruijin Hospital

Recruiting

Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study (AEGIS)

Esophagogastric Junction Adenocarcinoma

China
E-DA Hospital

Not yet recruiting

Risk Factors Affect Weight Loss Outcomes After Treatment (WRRFA).

Weight Regain
Peking University People's Hospital

Recruiting

Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota

Antibiotics Affecting Newborn Gut Microbiota

China
University Health Network, Toronto
Ontario Shores Centre for Mental Health Sciences

Recruiting

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial (Ket-CBT)

Suicide | Major Depressive Disorder | Treatment Resistant Depression

Canada
Anhui Provincial Hospital
Beijing Pins Medical Co., Ltd

Recruiting

Differences in Brain Network Mechanisms Between STN and GPi Deep Brain Stimulation in the Treatment of Craniocervical Dystonia

Dystonia

China
Baylor College of Medicine
National Institute of Mental Health (NIMH)

Recruiting

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Healthy | Major Depressive Disorder | Treatment Resistant Depression

United States
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

Stem Cell Derived Exome for Treatment of Diabetic Foot

Diabetic Foot | Stem Cell

China
Ain Shams University

Recruiting

Radiofrequency Plus Superficial Cervical Plexus Block in Treatment of Cervical Spondylosis Pain

Neck Pain | Cervical Spondylosis

Egypt
Zhuhai Tonbridge Medical Tech. Co., Ltd.

Not yet recruiting

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

Intracranial Arteriovenous Malformations

China
University of Malaya

Recruiting

Radiation Free Fistuloplasty is the Way Forward

Fistulas Arteriovenous

Malaysia
Rigshospitalet, Denmark
Danish Cancer Society

Recruiting

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Denmark
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment

NSCLC

Search clinical trials for: Immunotherapeutic treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations